WO2004037325A1 - Blood vessel needle using biodegradable materials - Google Patents

Blood vessel needle using biodegradable materials Download PDF

Info

Publication number
WO2004037325A1
WO2004037325A1 PCT/KR2003/001457 KR0301457W WO2004037325A1 WO 2004037325 A1 WO2004037325 A1 WO 2004037325A1 KR 0301457 W KR0301457 W KR 0301457W WO 2004037325 A1 WO2004037325 A1 WO 2004037325A1
Authority
WO
WIPO (PCT)
Prior art keywords
needle
needle tube
tube
blood vessel
tubular body
Prior art date
Application number
PCT/KR2003/001457
Other languages
French (fr)
Inventor
Jae-Kyun Doo
Man-Su Yang
Hyo-Yeol Kim
Yoon Cho
Do-Youn Kim
Original Assignee
Ire Chemical Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ire Chemical Ltd. filed Critical Ire Chemical Ltd.
Publication of WO2004037325A1 publication Critical patent/WO2004037325A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/329—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles characterised by features of the needle shaft

Definitions

  • the present invention relates to a medical needle used for intravascular injection, and more particularly to an intravascular injection needle made of biodegradable compounds, which is configured to have sufficient hardness to pierce the skin of a patient without using a metal guide needle, and to allow the needle to soften once it is inserted into a blood vessel due to a patient's body temperature, and moisture and enzymes present in the blood vessel.
  • an intravascular needle tube is used to continuously supply a medical fluid such as infusion solution or injection into a blood vessel of a patient.
  • This kind of needle tube is conventionally referred to as an infusion set or catheter.
  • the intravascular needle tube as one of fundamental parts of the infusion set, comprises a metal guide needle and a synthetic resin tube (i.e. Teflon tube) adapted to be fitted around the metal guide needle, in order to prevent accidental damage to a blood vessel due to normal patient movement.
  • the metal guide needle has a function of initial penetration of the skin and blood vessel in order to lead the synthetic resin tube surrounding it into the blood vessel.
  • the synthetic resin tube formed as a flexible synthetic resin tube, is adapted to be inserted into the blood vessel while coming into close contact with the outer surface of the metal guide needle at its inner surface. After being inserted, the synthetic resin tube is coupled with an infusion solution tube so as to supply infusion solution or injection into the blood vessel.
  • the metal guide needle is adapted to be discarded after it completes its function of leading the synthetic resin tube into the blood vessel.
  • disposal of the metal guide needle increases the volume of hazardous waste and. furthermore, increases a price of a disposable intravascular injection needle.
  • the synthetic resin tube is provided with a metal eyelet. The formation of such a metal eyelet complicates the overall manufacturing process of the synthetic resin tube.
  • biodegradable high-molecular weight compounds suitable for use as biomedical compounds are polylactide(PLA) and polyglycolide, or copolymers thereof. These biodegradable high-molecular weight compounds are actually used in the medical field as surgical sutures, due to their high biocompatibility.
  • active research and development is targeting artificial skin, injury -treatment accelerators and so on using chitosan as a natural high molecular weight compound.
  • the present invention has been made in view of the above problems, and it is an object of the present invention to provide a needle for intravascular injection, which is configured to have sufficient hardness to pierce the skin and blood vessel of a patient at room temperature, and to increase the flexibility of a needle tube, while losing the sharpness of a tip of the needle tube due to a patient's body temperature, and moisture and enzymes present in blood once it is inserted into a blood vessel.
  • a needle for intravascular injection comprising a needle tube including a tubular body and a needle formed at a tip of the tubular body; and a hub coupled to an end of the needle tube opposite to the tip of the tubular body, the needle tube being made of a composition including biodegradable synthetic high-molecular weight compounds and 1 to 10 percent by weight of starch, based on the total weight of the composition.
  • the needle of the present invention is adapted to soften within a patient's body.
  • the needle of the present invention constructed as stated above, the needle is integrally formed at the tip of the tubular body, unlike a general intravascular injection needle, thereby eliminating the use of a conventional metal guide needle.
  • the conventional metal guide needle is an essential part of the general intravascular injection needle (i.e. catheter).
  • the needle tube according to the present invention is made of a composition including at least two kinds of biodegradable synthetic high- molecular weight compounds and starch.
  • the starch is added to the biodegradable synthetic high-molecular weight compounds so that starch particles having a diameter of not more than 20 micrometers are contained in the high- molecular weight matrix constituting the tube.
  • the needle tube constructed as described above shows similar hardness and strength to the metal guide needle during its initial injection and penetration of a blood vessel. Then, once the needle tube is inserted into the blood vessel, the needle tube is adapted to soften, thereby having a similar flexibility to a synthetic resin tube.
  • the biodegradable high-molecular weight compounds may be polylactide(PLA) (or copolymers thereof), and polybutylenesuccinate(PBS) (or copolymers thereof).
  • the polylactide(PLA) (or copolymers thereof) has a high degree of hardness and strength, thereby allowing the needle tube containing polylactide to easily pierce the skin of a patient.
  • the polybutylenesuccinate(PBS) (or copolymers thereof) serves to improve processibility of polylactide(PLA) and to secure softening of the needle tube when the needle tube is inserted into a patient's body, thereby facilitating free movement of a patient.
  • a weight ratio of polylactide(PLA) (or copolymers thereof) to polybutylenesuccinate(PBS) (or copolymers thereof) may be selected appropriately in the range of 90: 10 to 50:50, in accordance with a size and use purpose of the needle tube. If the content of polylactide(PLA) (or copolymers thereof) is more than 90 percent by weight, hardness of the needle tube is increased, while processibility and flexibility thereof are reduced. On the other hand, if the content of polylactide(PLA) (or copolymers thereof) is not more than 50 percent by weight, even hardness of the needle tube is reduced, thereby making the needle tube fail to pierce the skin of a patient.
  • a most preferable weight ratio of polylactide(PLA) (or copolymers thereof) to polybutylenesuccinate(PBS) (or copolymers thereof) is in the range of 80:20 to 65:35. In this range, the needle tube shows a high level of hardness and processibility.
  • the starch as one component of the needle tube, it is adapted to be dissolved gradually when the needle tube is inserted into the blood vessel due to moisture and enzymes present in a blood vessel, thereby increasing the flexibility of the needle, while reducing the sharpness of the needle.
  • the used starch is mixed with the biodegradable high-molecular weight compounds to modify them, thereby obtaining in the form of thermoplastic starch(TPS).
  • the content of starch is in the range of 1 to 10 percent by weight, based on the total weight of the needle tube. If the content of starch is not more than 1 percent by weight, it is impossible to achieve a function of the starch. On the other hand, if the content of starch is more than 10 percent by weight, the processibility and mechanical properties of the needle tube are deteriorated.
  • the content of starch is preferably in the range of 3 to 5 percent by weight, it is possible to achieve the needle tube having a high level of processibility and optimal features able to achieve the objects of the present invention.
  • Fig. 1 is a schematic view illustrating a needle for intravascular injection in accordance with the present invention.
  • Example 1 A needle tube was manufactured by mixing polylactide, polybutylenesuccinate, and thermoplastic starch in the weight ratio of 65:30:5, and extruding the resulting mixture to have a certain outer diameter and thickness using a certain extruding apparatus.
  • a needle tube was manufactured by mixing polylactide, polybutylenesuccinate, and thermoplastic starch in the weight ratio of 75:22:3, and extruding the resulting mixture to have the same outer diameter and thickness as those of Example 1 using the extruding apparatus of Example 1.
  • Example 2 An animal experiment was performed for inserting the manufactured needle tube into an ear blood vessel of a rabbit as a laboratory animal, in the same manner as Example 1. As a result, it was found that the manufactured needle tube easily pierced the skin of the rabbit. In addition, it was confirmed that the sharpness of the distal portion of the needle tube was reduced and the needle tube was softened once it was inserted into the blood vessel.
  • a needle tube was manufactured by mixing polylactide, a polybutylenesuccinate-butyleneadipate copolymer, and thermoplastic starch in the weight ratio of 75:22:3, and extruding the resulting mixture to have the same outer diameter and thickness as those of Example 1 using the extruding apparatus of
  • Example 2 An animal experiment was performed for inserting the manufactured needle tube into an ear blood vessel of a rabbit as a laboratory animal, in the same manner as Example 1. As a result, it was found that the manufactured needle tube easily pierced the skin of the rabbit. In addition, it was confirmed that the sharpness of the distal portion of the needle tube was reduced and the needle tube was softened once it was inserted into the blood vessel.
  • a needle tube was manufactured by mixing a polylactide-glycolide copolymer, polybutylenesuccinate, and thermoplastic starch in the weight ratio of 70:25:5, and extruding the resulting mixture to have the same outer diameter and thickness as those of Example 1 using the extruding apparatus of Example 1.
  • Example 2 An animal experiment was performed for inserting the manufactured needle tube into an ear blood vessel of a rabbit as a laboratory animal, in the same manner as Example 1. As a result, it was found that the manufactured needle tube easily pierced the skin of the rabbit. In addition, it was confirmed that the sharpness of the distal portion of the needle tube was reduced and the needle tube was softened once it was inserted into the blood vessel.
  • the polylactide(PLA) constituting the needle tube in order to allow the needle tube to pierce the skin of a patient, the polylactide(PLA) constituting the needle tube must have a content at least exceeding 65 percent by weight, based on
  • the polylactide(PLA) also must have a content not exceeding 80 percent by weight.
  • the thermoplastic starch(TPS) In relation to the thermoplastic starch(TPS), it must have a content not exceeding 10 percent by weight, based on 100 percent by weight of the needle tube, in order to secure sufficient processibility of the needle tube.
  • the content of polylactide(PLA) (or copolymers thereof) may be in the range of 80 to 65 percent by weight
  • the content of polybutylenesuccinate(PBS) (or copolymers thereof) may be in the range of 20 to 35 percent by weight
  • the content of thermoplastic starch(TPS) may be in the range of 1 to 10 percent by weight.
  • the needle tube constructed according to above examples, is softened rapidly within 3 to 5 minutes once it is inserted into the blood vessel of a patient, and then the inserted needle tube usually stays in the blood vessel from 3 hours to 1 week until it is dissolved completely.
  • the needle tube viewed from the animal experiment, is softened at a constant rate starting from a rapid softening time point.
  • the needle tube made of a composition as stated above, may be processed by an injection molding method using a mold shaped into the form of the needle tube, or by an extrusion molding method using a tube extruder.
  • the used tube extruder employs the same manner as a general straw extruder, except that it is provided with a die having a diameter of not more than 5 mm and configured so that an extruding speed and a holding device thereof are accurately controlled.
  • the needle tube is manufactured using the extrusion molding method, it is necessary to process the end of the needle tube using a separate cutting device mounted in the extruder, while the injection molding method of the needle tube does not need a separate post-treatment.
  • a representative one of the cutting devices used for the processing of the needle tube is a cutting device adapted to rotate a blade in a diagonal direction, or a cutting device adapted to scan a laser beam at a constant angle.
  • Fig. 1 is a schematic view illustrating a needle for intravascular injection in accordance with the present invention.
  • the needle for intravascular injection comprises a needle tube, manufactured by extruding certain compounds as stated above.
  • the needle tube includes a tubular body 1 and a needle la formed at the tip of the tubular body 1.
  • a hub 2 is manufactured separately and then coupled to the end of the needle tube opposite to the tip of the tubular body 1.
  • the end of the needle tube opposite to the tip of the tubular body 1 is bonded inside a trumpet bell mouth 2a of the hub 2.
  • the trumpet bell mouth 2a of the hub 2 has a tapered shape and is adapted to perfectly receive an infusion solution tube 3.
  • the hub 2 may be made of various compositions, so long as it is made of a biodegradable high-molecular weight compound.
  • the hub 2 and needle tube including the tubular body 1 and needle are formed into single body, via the injection molding of certain compound as stated above.
  • the needle for intravascular injection according to the present invention is configured so that the needle is integrally formed at the plastic tubular body adapted to soften in infusion solution.
  • the present invention has a technical feature of not using a conventional metal guide needle, thereby allowing 5. the needle to be formed into various optimal shapes suitable for various uses thereof.
  • the configuration of the needle as described above is a representative configuration, given purely by way of example for explaining the present invention, and is not intended to exclude other possible configurations.
  • the present invention provides a needle for intravascular injection, which is formed by adding starch to biodegradable compounds.
  • the obtained needle has sufficient hardness to pierce the skin and blood vessel of a patient at room temperature.
  • the flexibility of the needle tube can 5 be increased, while the sharpness of needle portion can be reduced, due to a patient's body temperature, and moisture and enzymes present in blood.
  • the present invention by not using a metal guide needle, which has been used essentially in existing catheters or infusion sets, it is possible to reduce the volume of hazardous waste, to reduce the manufacturing cost thereof, and 0 to reduce safety hazards due to the metal needle.
  • the needle tube of the present invention is inserted into the body of a patient while being directly coupled with an infusion solution tube, it is possible to effectively solve a problem of leakage of blood during the coupling of the infusion solution tube.

Abstract

The present invention is made for achieving a needle for intravascular injection made of biodegradable compounds, which is configured to have sufficient hardness to pierce the skin of a patient without using a metal guide needle, and to allow the needle to soften once it is inserted into a blood vessel, due to a patient's body temperature, and moisture and enzymes present in the blood vessel. The needle of the present invention, requiring no metal guide needle, comprises a needle tube including a tubular body and a needle formed at a tip of the tubular body, and a hub coupled to an end of the needle tube opposite to the tip of the tubular body. The needle tube is made of a composition including biodegradable synthetic high-molecular weight compounds and 1 to 10 percent by weight of starch, based on the total weight of the composition.

Description

BLOOD VESSEL NEEDLE USING BIODEGRADABLE MATERIALS
Technical Field
The present invention relates to a medical needle used for intravascular injection, and more particularly to an intravascular injection needle made of biodegradable compounds, which is configured to have sufficient hardness to pierce the skin of a patient without using a metal guide needle, and to allow the needle to soften once it is inserted into a blood vessel due to a patient's body temperature, and moisture and enzymes present in the blood vessel.
Background Art
In general, an intravascular needle tube is used to continuously supply a medical fluid such as infusion solution or injection into a blood vessel of a patient.
This kind of needle tube is conventionally referred to as an infusion set or catheter.
Unlike general needles, the intravascular needle tube, as one of fundamental parts of the infusion set, comprises a metal guide needle and a synthetic resin tube (i.e. Teflon tube) adapted to be fitted around the metal guide needle, in order to prevent accidental damage to a blood vessel due to normal patient movement. The metal guide needle has a function of initial penetration of the skin and blood vessel in order to lead the synthetic resin tube surrounding it into the blood vessel. The synthetic resin tube, formed as a flexible synthetic resin tube, is adapted to be inserted into the blood vessel while coming into close contact with the outer surface of the metal guide needle at its inner surface. After being inserted, the synthetic resin tube is coupled with an infusion solution tube so as to supply infusion solution or injection into the blood vessel.
In the conventional needle tube for intravascular injection constructed as stated above, the metal guide needle is adapted to be discarded after it completes its function of leading the synthetic resin tube into the blood vessel. Such disposal of the metal guide needle increases the volume of hazardous waste and. furthermore, increases a price of a disposable intravascular injection needle. Further, in order to allow the metal guide needle to be inserted therein, the synthetic resin tube is provided with a metal eyelet. The formation of such a metal eyelet complicates the overall manufacturing process of the synthetic resin tube.
When the needle tube for intravascular injection is withdrawn from the blood vessel following penetration of the blood vessel and then connected with the infusion solution tube, there is a potential hazard associated with sudden gush of blood through a plastic tube from the blood vessel. In addition, during the removal of the metal guide needle, a surgeon may be pricked by the needle through carelessness, thus possibly becoming infected with fatal diseases.
Representative ones, among conventional biodegradable high-molecular weight compounds suitable for use as biomedical compounds, are polylactide(PLA) and polyglycolide, or copolymers thereof. These biodegradable high-molecular weight compounds are actually used in the medical field as surgical sutures, due to their high biocompatibility. Currently, active research and development is targeting artificial skin, injury -treatment accelerators and so on using chitosan as a natural high molecular weight compound.
Nevertheless, no needles for intravascular injection made of biodegradable high-molecular weight compounds have been reported yet, and thus it can be said that the present invention is a novel device.
Disclosure of the Invention
Therefore, the present invention has been made in view of the above problems, and it is an object of the present invention to provide a needle for intravascular injection, which is configured to have sufficient hardness to pierce the skin and blood vessel of a patient at room temperature, and to increase the flexibility of a needle tube, while losing the sharpness of a tip of the needle tube due to a patient's body temperature, and moisture and enzymes present in blood once it is inserted into a blood vessel.
In accordance with the present invention, the above and other objects can be accomplished by the provision of a needle for intravascular injection comprising a needle tube including a tubular body and a needle formed at a tip of the tubular body; and a hub coupled to an end of the needle tube opposite to the tip of the tubular body, the needle tube being made of a composition including biodegradable synthetic high-molecular weight compounds and 1 to 10 percent by weight of starch, based on the total weight of the composition. The needle of the present invention is adapted to soften within a patient's body.
In the needle of the present invention constructed as stated above, the needle is integrally formed at the tip of the tubular body, unlike a general intravascular injection needle, thereby eliminating the use of a conventional metal guide needle. The conventional metal guide needle is an essential part of the general intravascular injection needle (i.e. catheter).
The needle tube according to the present invention is made of a composition including at least two kinds of biodegradable synthetic high- molecular weight compounds and starch. The starch is added to the biodegradable synthetic high-molecular weight compounds so that starch particles having a diameter of not more than 20 micrometers are contained in the high- molecular weight matrix constituting the tube. The needle tube constructed as described above shows similar hardness and strength to the metal guide needle during its initial injection and penetration of a blood vessel. Then, once the needle tube is inserted into the blood vessel, the needle tube is adapted to soften, thereby having a similar flexibility to a synthetic resin tube.
The biodegradable high-molecular weight compounds may be polylactide(PLA) (or copolymers thereof), and polybutylenesuccinate(PBS) (or copolymers thereof).
The polylactide(PLA) (or copolymers thereof) has a high degree of hardness and strength, thereby allowing the needle tube containing polylactide to easily pierce the skin of a patient. The polybutylenesuccinate(PBS) (or copolymers thereof) serves to improve processibility of polylactide(PLA) and to secure softening of the needle tube when the needle tube is inserted into a patient's body, thereby facilitating free movement of a patient.
Considering the biodegradable high-molecular weight compounds, except the starch, a weight ratio of polylactide(PLA) (or copolymers thereof) to polybutylenesuccinate(PBS) (or copolymers thereof) may be selected appropriately in the range of 90: 10 to 50:50, in accordance with a size and use purpose of the needle tube. If the content of polylactide(PLA) (or copolymers thereof) is more than 90 percent by weight, hardness of the needle tube is increased, while processibility and flexibility thereof are reduced. On the other hand, if the content of polylactide(PLA) (or copolymers thereof) is not more than 50 percent by weight, even hardness of the needle tube is reduced, thereby making the needle tube fail to pierce the skin of a patient.
Therefore, a most preferable weight ratio of polylactide(PLA) (or copolymers thereof) to polybutylenesuccinate(PBS) (or copolymers thereof) is in the range of 80:20 to 65:35. In this range, the needle tube shows a high level of hardness and processibility.
Considering the starch as one component of the needle tube, it is adapted to be dissolved gradually when the needle tube is inserted into the blood vessel due to moisture and enzymes present in a blood vessel, thereby increasing the flexibility of the needle, while reducing the sharpness of the needle.
The used starch is mixed with the biodegradable high-molecular weight compounds to modify them, thereby obtaining in the form of thermoplastic starch(TPS). The content of starch is in the range of 1 to 10 percent by weight, based on the total weight of the needle tube. If the content of starch is not more than 1 percent by weight, it is impossible to achieve a function of the starch. On the other hand, if the content of starch is more than 10 percent by weight, the processibility and mechanical properties of the needle tube are deteriorated.
Therefore, where the content of starch is preferably in the range of 3 to 5 percent by weight, it is possible to achieve the needle tube having a high level of processibility and optimal features able to achieve the objects of the present invention.
Brief Description of the Drawings
The above and other objects, features and other advantages of the present invention will be more clearly understood from the following detailed description taken in conjunction with the accompanying drawings, in which:
Fig. 1 is a schematic view illustrating a needle for intravascular injection in accordance with the present invention.
Best Mode for Carrying Out the Invention
Examples Now, preferable examples of the present invention will be described as follows.
Example 1 A needle tube was manufactured by mixing polylactide, polybutylenesuccinate, and thermoplastic starch in the weight ratio of 65:30:5, and extruding the resulting mixture to have a certain outer diameter and thickness using a certain extruding apparatus.
Then, an animal experiment was performed for inserting the manufactured needle tube into an ear blood vessel of a rabbit as a laboratory animal. As a result, it was found that the manufactured needle tube easily pierced the skin of the rabbit. In addition, it was confirmed that the sharpness of the distal portion of the needle tube was reduced and the needle tube was softened once it was inserted into the blood vessel.
Example 2
A needle tube was manufactured by mixing polylactide, polybutylenesuccinate, and thermoplastic starch in the weight ratio of 75:22:3, and extruding the resulting mixture to have the same outer diameter and thickness as those of Example 1 using the extruding apparatus of Example 1.
Then, an animal experiment was performed for inserting the manufactured needle tube into an ear blood vessel of a rabbit as a laboratory animal, in the same manner as Example 1. As a result, it was found that the manufactured needle tube easily pierced the skin of the rabbit. In addition, it was confirmed that the sharpness of the distal portion of the needle tube was reduced and the needle tube was softened once it was inserted into the blood vessel.
Example 3
A needle tube was manufactured by mixing polylactide, a polybutylenesuccinate-butyleneadipate copolymer, and thermoplastic starch in the weight ratio of 75:22:3, and extruding the resulting mixture to have the same outer diameter and thickness as those of Example 1 using the extruding apparatus of
Example 1.
Then, an animal experiment was performed for inserting the manufactured needle tube into an ear blood vessel of a rabbit as a laboratory animal, in the same manner as Example 1. As a result, it was found that the manufactured needle tube easily pierced the skin of the rabbit. In addition, it was confirmed that the sharpness of the distal portion of the needle tube was reduced and the needle tube was softened once it was inserted into the blood vessel.
Example 4
A needle tube was manufactured by mixing a polylactide-glycolide copolymer, polybutylenesuccinate, and thermoplastic starch in the weight ratio of 70:25:5, and extruding the resulting mixture to have the same outer diameter and thickness as those of Example 1 using the extruding apparatus of Example 1.
Then, an animal experiment was performed for inserting the manufactured needle tube into an ear blood vessel of a rabbit as a laboratory animal, in the same manner as Example 1. As a result, it was found that the manufactured needle tube easily pierced the skin of the rabbit. In addition, it was confirmed that the sharpness of the distal portion of the needle tube was reduced and the needle tube was softened once it was inserted into the blood vessel.
As may be seen from the results of foregoing examples, in order to allow the needle tube to pierce the skin of a patient, the polylactide(PLA) constituting the needle tube must have a content at least exceeding 65 percent by weight, based on
100 percent by weight of the needle tube. On the other hand, in order to increase processibility of the needle tube as well as to prevent the needle tube from being broken, the polylactide(PLA) also must have a content not exceeding 80 percent by weight. In relation to the thermoplastic starch(TPS), it must have a content not exceeding 10 percent by weight, based on 100 percent by weight of the needle tube, in order to secure sufficient processibility of the needle tube.
More preferably, the content of polylactide(PLA) (or copolymers thereof) may be in the range of 80 to 65 percent by weight, the content of polybutylenesuccinate(PBS) (or copolymers thereof) may be in the range of 20 to 35 percent by weight, and the content of thermoplastic starch(TPS) may be in the range of 1 to 10 percent by weight. These contents are based on 100 percent by weight of the needle tube.
As a result of clinical tests, the needle tube, constructed according to above examples, is softened rapidly within 3 to 5 minutes once it is inserted into the blood vessel of a patient, and then the inserted needle tube usually stays in the blood vessel from 3 hours to 1 week until it is dissolved completely. Similarly, the needle tube, viewed from the animal experiment, is softened at a constant rate starting from a rapid softening time point.
Referring to the processing method of the needle tube in accordance with the present invention, the needle tube, made of a composition as stated above, may be processed by an injection molding method using a mold shaped into the form of the needle tube, or by an extrusion molding method using a tube extruder. In the case of extrusion molding, the used tube extruder employs the same manner as a general straw extruder, except that it is provided with a die having a diameter of not more than 5 mm and configured so that an extruding speed and a holding device thereof are accurately controlled.
Specifically, where the needle tube is manufactured using the extrusion molding method, it is necessary to process the end of the needle tube using a separate cutting device mounted in the extruder, while the injection molding method of the needle tube does not need a separate post-treatment.
A representative one of the cutting devices used for the processing of the needle tube is a cutting device adapted to rotate a blade in a diagonal direction, or a cutting device adapted to scan a laser beam at a constant angle.
Fig. 1 is a schematic view illustrating a needle for intravascular injection in accordance with the present invention. Referring to Fig. 1, the needle for intravascular injection comprises a needle tube, manufactured by extruding certain compounds as stated above. The needle tube includes a tubular body 1 and a needle la formed at the tip of the tubular body 1. A hub 2 is manufactured separately and then coupled to the end of the needle tube opposite to the tip of the tubular body 1. Specifically, the end of the needle tube opposite to the tip of the tubular body 1 is bonded inside a trumpet bell mouth 2a of the hub 2. The trumpet bell mouth 2a of the hub 2 has a tapered shape and is adapted to perfectly receive an infusion solution tube 3.
The hub 2 may be made of various compositions, so long as it is made of a biodegradable high-molecular weight compound.
According to the present invention, the hub 2 and needle tube including the tubular body 1 and needle are formed into single body, via the injection molding of certain compound as stated above. Thus, since the needle for intravascular injection is manufactured through only one molding process, a price of products can be reduced by virtue of simplification of manufacturing process. The needle for intravascular injection according to the present invention is configured so that the needle is integrally formed at the plastic tubular body adapted to soften in infusion solution. Namely, the present invention has a technical feature of not using a conventional metal guide needle, thereby allowing 5. the needle to be formed into various optimal shapes suitable for various uses thereof. The configuration of the needle as described above is a representative configuration, given purely by way of example for explaining the present invention, and is not intended to exclude other possible configurations.
Industrial Applicability
0 As apparent from the above description, the present invention provides a needle for intravascular injection, which is formed by adding starch to biodegradable compounds. The obtained needle has sufficient hardness to pierce the skin and blood vessel of a patient at room temperature. In addition, once the needle tube is inserted into the blood vessel, the flexibility of the needle tube can 5 be increased, while the sharpness of needle portion can be reduced, due to a patient's body temperature, and moisture and enzymes present in blood.
According to the present invention, by not using a metal guide needle, which has been used essentially in existing catheters or infusion sets, it is possible to reduce the volume of hazardous waste, to reduce the manufacturing cost thereof, and 0 to reduce safety hazards due to the metal needle. In addition, since the needle tube of the present invention is inserted into the body of a patient while being directly coupled with an infusion solution tube, it is possible to effectively solve a problem of leakage of blood during the coupling of the infusion solution tube.
Although the preferred embodiments of the present invention have been 5 disclosed for illustrative purposes, those skilled in the art will appreciate that various modifications, additions and substitutions are possible, without departing from the scope and spirit of the invention as disclosed in the accompanying claims.

Claims

Claims:
1. A needle for intravascular injection, requiring no metal guide needle, comprising: a needle tube including a tubular body and a needle formed at a tip of the tubular body; and a hub coupled to an end of the needle tube opposite to the tip of the tubular body, the needle tube being made of a composition including biodegradable synthetic high-molecular weight compounds and 1 to 10 percent by weight of starch, based on the total weight of the composition.
2. The needle for intravascular injection as set forth in claim 1, wherein the synthetic high-molecular weight compounds are polylactide(PLA) and polybutylenesuccinate(PBS) in a weight ratio of 90:10 to 50:50.
3. The needle for intravascular injection as set forth in claim 1 , wherein the synthetic high-molecular weight compounds are a polylactide copolymer and a polybutylenesuccinate copolymer in a weight ratio of 90:10 to 50:50 .
4. The needle for intravascular injection as set forth in claim 1, wherein the needle tube including the tubular body and needle, and the hub coupled to the the tubular body are formed into single body made of the composition including the synthetic high-molecular weight compounds and starch.
5. The needle for intravascular injection as set forth in claim 1, wherein: the needle tube, including the tubular body and needle, is made of the composition including the synthetic high-molecular weight compounds and starch; and the hub is made of other compositions and then attached to the needle tube.
PCT/KR2003/001457 2002-10-22 2003-07-22 Blood vessel needle using biodegradable materials WO2004037325A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2002-0064615A KR100481420B1 (en) 2002-10-22 2002-10-22 Blood vessel needle using biodegradable materials
KR10-2002-0064615 2002-10-22

Publications (1)

Publication Number Publication Date
WO2004037325A1 true WO2004037325A1 (en) 2004-05-06

Family

ID=27728915

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2003/001457 WO2004037325A1 (en) 2002-10-22 2003-07-22 Blood vessel needle using biodegradable materials

Country Status (2)

Country Link
KR (1) KR100481420B1 (en)
WO (1) WO2004037325A1 (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006074948A1 (en) * 2005-01-13 2006-07-20 Disetronic Licensing Ag Flexible injection needle
WO2008092958A3 (en) * 2007-02-02 2008-12-04 Unomedical As A gateway device
US7985199B2 (en) 2005-03-17 2011-07-26 Unomedical A/S Gateway system
US8012126B2 (en) 2006-10-31 2011-09-06 Unomedical A/S Infusion set
US8062250B2 (en) 2004-08-10 2011-11-22 Unomedical A/S Cannula device
US8221355B2 (en) 2004-03-26 2012-07-17 Unomedical A/S Injection device for infusion set
US8246588B2 (en) 2007-07-18 2012-08-21 Unomedical A/S Insertion device with pivoting action
US8303549B2 (en) 2005-12-23 2012-11-06 Unomedical A/S Injection device
US8430850B2 (en) 2007-07-03 2013-04-30 Unomedical A/S Inserter having bistable equilibrium states
US8439838B2 (en) 2006-06-07 2013-05-14 Unomedical A/S Inserter for transcutaneous sensor
US8486003B2 (en) 2007-07-10 2013-07-16 Unomedical A/S Inserter having two springs
US8562567B2 (en) 2009-07-30 2013-10-22 Unomedical A/S Inserter device with horizontal moving part
WO2014040886A1 (en) * 2012-09-14 2014-03-20 Fresenius Kabi Deutschland Gmbh Medical injection device
US8790311B2 (en) 2006-06-09 2014-07-29 Unomedical A/S Mounting pad
US8945057B2 (en) 2006-08-02 2015-02-03 Unomedical A/S Cannula and delivery device
US9186480B2 (en) 2007-06-20 2015-11-17 Unomedical A/S Apparatus for making a catheter
US9211379B2 (en) 2006-02-28 2015-12-15 Unomedical A/S Inserter for infusion part and infusion part provided with needle protector
US9254373B2 (en) 2008-12-22 2016-02-09 Unomedical A/S Medical device comprising adhesive pad
US9415159B2 (en) 2010-03-30 2016-08-16 Unomedical A/S Medical device
US9440051B2 (en) 2011-10-27 2016-09-13 Unomedical A/S Inserter for a multiplicity of subcutaneous parts
US9533092B2 (en) 2009-08-07 2017-01-03 Unomedical A/S Base part for a medication delivery device
US9566384B2 (en) 2008-02-20 2017-02-14 Unomedical A/S Insertion device with horizontally moving part
US9724127B2 (en) 2010-09-27 2017-08-08 Unomedical A/S Insertion system and insertion kit
US10369277B2 (en) 2005-09-12 2019-08-06 Unomedical A/S Invisible needle
US10898643B2 (en) 2008-02-13 2021-01-26 Unomedical A/S Sealing between a cannula part and a fluid path
WO2021083630A1 (en) * 2019-10-31 2021-05-06 Raumedic Ag Infusion cannula unit made of plastic
US11020526B2 (en) 2010-10-04 2021-06-01 Unomedical A/S Sprinkler cannula
US11110261B2 (en) 2011-10-19 2021-09-07 Unomedical A/S Infusion tube system and method for manufacture
US11197689B2 (en) 2011-10-05 2021-12-14 Unomedical A/S Inserter for simultaneous insertion of multiple transcutaneous parts
US11938309B2 (en) 2020-07-28 2024-03-26 Neogen Corporation Hypodermic interface assembly

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687320A1 (en) * 1992-02-17 1993-08-20 Ruiz Paul Retractile and biodegradable hypodermic syringe
US5858244A (en) * 1996-07-16 1999-01-12 Nalco Chemical Company Use of biodegradable polymers in prevention scale build-up
KR19990022514U (en) * 1999-03-10 1999-07-05 이국성 Aaaaa
KR20010060152A (en) * 1999-12-21 2001-07-06 서관호 A process of preparing crosslinked polyester goods
US20020022855A1 (en) * 1997-12-31 2002-02-21 Bobroff Randa M. Insertion device for an insertion set and method of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960012445B1 (en) * 1992-11-24 1996-09-20 주식회사 유공 Biodegradable polyethylene composition coupled chemically by starch and process thereof
US5759569A (en) * 1995-01-10 1998-06-02 The Procter & Gamble Company Biodegradable articles made from certain trans-polymers and blends thereof with other biodegradable components
DE19638488A1 (en) * 1996-09-20 1998-03-26 Basf Ag Biodegradable polyester
CN1258542A (en) * 1998-12-29 2000-07-05 徐彦生 Disposable self-destructing syringe and its making process
KR20010081686A (en) * 2000-02-18 2001-08-29 윤여생 Disposable syringe of biodegradation property

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687320A1 (en) * 1992-02-17 1993-08-20 Ruiz Paul Retractile and biodegradable hypodermic syringe
US5858244A (en) * 1996-07-16 1999-01-12 Nalco Chemical Company Use of biodegradable polymers in prevention scale build-up
US20020022855A1 (en) * 1997-12-31 2002-02-21 Bobroff Randa M. Insertion device for an insertion set and method of using the same
KR19990022514U (en) * 1999-03-10 1999-07-05 이국성 Aaaaa
KR20010060152A (en) * 1999-12-21 2001-07-06 서관호 A process of preparing crosslinked polyester goods

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8221355B2 (en) 2004-03-26 2012-07-17 Unomedical A/S Injection device for infusion set
US8287516B2 (en) 2004-03-26 2012-10-16 Unomedical A/S Infusion set
US8062250B2 (en) 2004-08-10 2011-11-22 Unomedical A/S Cannula device
WO2006074948A1 (en) * 2005-01-13 2006-07-20 Disetronic Licensing Ag Flexible injection needle
US7985199B2 (en) 2005-03-17 2011-07-26 Unomedical A/S Gateway system
US10369277B2 (en) 2005-09-12 2019-08-06 Unomedical A/S Invisible needle
US9278173B2 (en) 2005-12-23 2016-03-08 Unomedical A/S Device for administration
US8303549B2 (en) 2005-12-23 2012-11-06 Unomedical A/S Injection device
US9211379B2 (en) 2006-02-28 2015-12-15 Unomedical A/S Inserter for infusion part and infusion part provided with needle protector
US8439838B2 (en) 2006-06-07 2013-05-14 Unomedical A/S Inserter for transcutaneous sensor
US8790311B2 (en) 2006-06-09 2014-07-29 Unomedical A/S Mounting pad
US8945057B2 (en) 2006-08-02 2015-02-03 Unomedical A/S Cannula and delivery device
US8012126B2 (en) 2006-10-31 2011-09-06 Unomedical A/S Infusion set
WO2008092958A3 (en) * 2007-02-02 2008-12-04 Unomedical As A gateway device
US9320869B2 (en) 2007-06-20 2016-04-26 Unomedical A/S Apparatus for making a catheter
US9186480B2 (en) 2007-06-20 2015-11-17 Unomedical A/S Apparatus for making a catheter
US8430850B2 (en) 2007-07-03 2013-04-30 Unomedical A/S Inserter having bistable equilibrium states
US8486003B2 (en) 2007-07-10 2013-07-16 Unomedical A/S Inserter having two springs
US8246588B2 (en) 2007-07-18 2012-08-21 Unomedical A/S Insertion device with pivoting action
US10898643B2 (en) 2008-02-13 2021-01-26 Unomedical A/S Sealing between a cannula part and a fluid path
US10376637B2 (en) 2008-02-20 2019-08-13 Unomedical A/S Insertion device with horizontally moving part
US9566384B2 (en) 2008-02-20 2017-02-14 Unomedical A/S Insertion device with horizontally moving part
US9254373B2 (en) 2008-12-22 2016-02-09 Unomedical A/S Medical device comprising adhesive pad
US8562567B2 (en) 2009-07-30 2013-10-22 Unomedical A/S Inserter device with horizontal moving part
US9533092B2 (en) 2009-08-07 2017-01-03 Unomedical A/S Base part for a medication delivery device
US11786653B2 (en) 2010-03-30 2023-10-17 Unomedical A/S Insertion device
US9415159B2 (en) 2010-03-30 2016-08-16 Unomedical A/S Medical device
US9724127B2 (en) 2010-09-27 2017-08-08 Unomedical A/S Insertion system and insertion kit
US11020526B2 (en) 2010-10-04 2021-06-01 Unomedical A/S Sprinkler cannula
US11197689B2 (en) 2011-10-05 2021-12-14 Unomedical A/S Inserter for simultaneous insertion of multiple transcutaneous parts
US11684767B2 (en) 2011-10-19 2023-06-27 Unomedical A/S Infusion tube system and method for manufacture
US11110261B2 (en) 2011-10-19 2021-09-07 Unomedical A/S Infusion tube system and method for manufacture
US9440051B2 (en) 2011-10-27 2016-09-13 Unomedical A/S Inserter for a multiplicity of subcutaneous parts
WO2014040886A1 (en) * 2012-09-14 2014-03-20 Fresenius Kabi Deutschland Gmbh Medical injection device
WO2021083630A1 (en) * 2019-10-31 2021-05-06 Raumedic Ag Infusion cannula unit made of plastic
CN114929308A (en) * 2019-10-31 2022-08-19 诺美德科股份有限公司 Infusion cannula unit made of plastic
US11938309B2 (en) 2020-07-28 2024-03-26 Neogen Corporation Hypodermic interface assembly

Also Published As

Publication number Publication date
KR100481420B1 (en) 2005-04-08
KR20020086420A (en) 2002-11-18

Similar Documents

Publication Publication Date Title
WO2004037325A1 (en) Blood vessel needle using biodegradable materials
CA1276850C (en) Polymeric hypodermic device
US5250066A (en) Plastic pointed articles and method for their preparation
US5129889A (en) Synthetic absorbable epidural catheter
JPH0630168Y2 (en) Nozzle for biological tissue adhesive
US4900304A (en) Solid preparation administering instrument
US4840622A (en) Kink resistant catheter
US6096012A (en) Coated one-piece composite plastic catheter and cannula
EP1883495B1 (en) Methods of manufacturing a hard coated cannula
CN1151859A (en) One-way suture retaining device for braided sutures
JPH025429B2 (en)
EP1266669B1 (en) Medical syringe needle
JPH06327772A (en) Plastic cannula and its production
JP2004057516A (en) Double needle assembly
GB2282760A (en) Degradable surgical needle
US20020169426A1 (en) Injection needle
JP2004358016A (en) Puncture needle easily inserted along puncture route
CN213466439U (en) Novel parotid gland radiography injection catheter
EP3919100A1 (en) Indwelling subcutaneous administration needle
JPH03295566A (en) Piercing needle
KR20090031891A (en) End portion for hermetically sealed container having fine opening surface obtained easily by cleavage
JP4407270B2 (en) Living body insertion catheter
JP2000262629A (en) Medical appliance for intra-vascular insertion
JPS6122987B2 (en)
JPS63292966A (en) Solid formulation administering jig

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP